Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cyclic Lipodepsipeptides: A New Class of Antibacterial Agents in the Battle Against Resistant Bacteria

1 Jul 2013

Abstract excerpt

In order to provide effective treatment options for infections caused by multidrug-resistant bacteria, innovative antibiotics are necessary, preferably with novel modes of action and/or belonging to novel classes of drugs. Naturally occurring cyclic lipodepsipeptides, which contain one or more ester bonds along with the amide bonds, have emerged as promising candidates for the development of new antibiotics. Some...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Cancer therapeutics and mechanisms
Share to Microbial Natural Products and Biosynthesis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23859209
DOI: 10.4155/fmc.13.86

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cyclic Lipodepsipeptides: A New Class of Antibacterial Agents in the Battle Against Resistant BacteriaPMID 23859209Read ↗

Nonribosomal antibacterial peptides that target multidrug-resistant bacteriaSemantic proximity Read ↗

Isolation and partial characterization of cyclic lipopeptide antibiotics produced by Paenibacillus ehimensis B7Semantic proximity Read ↗

Antibacterial PeptidesSemantic proximity Read ↗

Development of Peptides that Inhibit Aminoglycoside-Modifying Enzymes and β-Lactamases for Control of Resistant BacteriaSemantic proximity Read ↗

Bioinformatic prospecting and synthesis of a bifunctional lipopeptide antibiotic that evades resistanceSemantic proximity Read ↗

In Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human PathogensSemantic proximity Read ↗

An Update of Peptides With Therapeutic Potential Against <em>Acinetobacter baumannii </em>InfectionsSemantic proximity Read ↗

Myxobacteria as a Source of New Bioactive Compounds: A Perspective StudySemantic proximity Read ↗

Cyclic lipopeptide natural products as taxa-specific antibacterial inhibitors of the lipid II flippaseSemantic proximity Read ↗

One ring to rule them all: Current trends in combating bacterial resistance to the β‐lactamsSemantic proximity Read ↗

Antimicrobial activity of cationic antimicrobial peptides against stationary phase bacteriaSemantic proximity Read ↗

Bacillus licheniformis – A Perspective for Medical Applications Producer of Variety of Antimicrobial Substances Including AntimycobacterialsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.